To include your compound in the COVID-19 Resource Center, submit it here.

Vaxfectin-formulated H1N1 vaccine: Phase I data

A double-blind, placebo-controlled, U.S. Phase I trial in about 30 healthy adult

Read the full 121 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE